Antiphosph
Internal Medicine
2023-11-29

Antiphospholipid Antibodies Increase Risk of Cardiovascular Disease in Patients With Lupus

Patients with systemic lupus erythematosus (SLE) who are positive for antiphospholipid (aPL) antibody isotypes immunoglobulin (Ig)G/IgM and lupus anticoagulant (LA) have an increased risk of atherosclerotic cardiovascular disease (ASCVD), according to a study presented at the 2023 Annual Meeting of the American College of Rheumatology (ACR). “Increased care and follow-up surveillance of these patients could be prudent in preventing cardiovascular disease,” said Yufang Ding, Peking Union Medical College Hospital, Peking, China. The multicentre prospective Chinese SLE treatment and researc...

Internal Medicine
2023-11-27

The cardiovascular effects of novel weight loss therapies

The prevalence of overweight and obesity has reached pandemic proportions. Obesity is known to increase the risk for Type 2 diabetes and hypertension, as well as the risk for overt cardiovascular (CV) disease, including myocardial infarction, heart f...

Internal Medicine
2023-11-24

AI Technology Improves Detection of Heart Disease During, After Pregnancy

Electrocardiogram (EKG)-based screening using an artificial intelligence (AI)-enabled digital stethoscope may detect peripartum cardiomyopathy at double the rate of standard obstetric care including clinical EKGs, according to late-breaking science p...

Videos from category: Cardiology

State of a
10:39

State of art lipid-lowering treatment in 2023

ESC 2023
The import
14:17

The importance of intensive lipid lowering in CV risk reduction: the role of early combination treatment

ESC 2023
Key points
7:23

Key points from the 2023 Focused update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

ESC 2023
Heart Fail
2:32

Heart Failure management in the post-COVID era - Lessons from the pandemic

ESC 2023

Videos from category: Diabetology

Targeting
9:22

Targeting CV risk factors with GLP-1 RAs in people with obesity

EASD 2022
Once weekl
7:36

Once weekly insulin: The ONWARDS 2 study

EASD 2022
Is HFpEF h
20:42

Is HFpEF hiding in your practice? Key messages of the DELIVER study: Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

EASD 2022
Semaglutid
7:29

Semaglutide 2.4 mg improved glucose metabolism and reverted prediabetes to normoglycaemia in adults with overweight or obesity vs liraglutide 3.0 mg

EASD 2022

Videos from category: Hematology

LMWH use i
6:49

LMWH use in pregnancy: The Highlow and the ALPINE trial

ASH 2022
Novelties
12:44

Novelties in the treatment of multiple myeloma 2021

ASH 2021
Risks for
5:01

Risks for Hospitalization and Death Among Patients with Blood Disorders from the ASH RC COVID-19 Registry for Hematology

ASH 2021
Novelties
8:35

Novelties in the treatment of myelofibrosis and polycythemia vera 2021

ASH 2021

Videos from category: Internal Medicine

Anticoagul
8:47

Anticoagulant Advancements for VTE in Children

ISTH 2022
The Journe
3:15

The Journey to Address Unmet Needs Across all Haemophilia Indications

ISTH 2022
Clinical C
6:18

Clinical Challenges in Patients with Venous Thromboembolism

ISTH 2022
Good pract
19:37

Good practice statements for antithrombotic therapy in the management of COVID-19

ISTH 2022

Videos from category: Oncology

Lung Cance
13:28

Lung Cancer highlights of ESMO 2023 Congress

ESMO 2023
Lung cance
10:26

Lung cancer highlights of the ESMO 2023 Congress

ESMO 2023
Melanoma h
8:15

Melanoma highlights of ESMO 2023 Congress

ESMO 2023
RCC highli
6:30

RCC highlights of ESMO 2023 Congress

ESMO 2023

Videos from category: Psychiatry

Current is
13:39

Current issues in the treatment of schizophrenia

EPA 2023
Highlights
10:47

Highlights of EPA 2023

EPA 2023
Novel Phar
8:13

Novel Pharmacotherapeutic Strategies for Regaining Control over Alcohol Intake in Alcohol Use Disorder

EPA 2021
Meeting th
15:41

Meeting the challenges of schizophrenia care during the COVID-19 pandemic

EPA 2021

Videos from category: Respiratory

Considerat
8:14

Considerations of moderate asthma management

ERS 2023
Choices in
10:06

Choices in asthma and COPD care: How to maximize outcomes for patients

ERS 2022
The digita
11:38

The digital age: The future of respiratory medicine

ERS 2021
Pulmonary
7:05

Pulmonary hypertension and interstitial pulmonary fibrosis

ERS 2021

Sixty Seconds Science

1:00
How to manage isolated systolic hypertension in the young?
1:34
Blood pressure monitoring in general and what we can do to encourage people.
1:08
How to manage masked and masked uncontrolled hypertension?
1:13
ESMO 2023 Scientific Chair's welcome and invitation to next year's ESMO Congress
1:17
Once-weekly semaglutide in people with HFpEF and obesity
1:31
Should ABPM parameters have a role in clinical practice?
1:09
On the most important key points on the diagnosis of Hypertension in the new ESH2023 guidelines
1:13
2023 ESC Guidelines for the Management of Endocarditis
1:37
How to measure blood pressure in the very obese patients?
1:14
The keypoints of 2023 ESC Guidelines for the Management of Cardiomyopathies
1:20
How to best perform office blood pressure management?
1:09
Key points from the newly updated ESC Heart Failure guidelines
0:54
Do overweight and obesity confer an additional risk of CAD in patients with FH?
1:17
Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer
1:17
The Omega-3 Mystery: New Evidence Supports the Therapeutic Value of EPA
1:15
The issue of adjuvant vs neoadjuvant treatment
1:19
The treatment sequence in metastatic melanoma
1:12
LMWH use in pregnancy: The ALPINE trial
1:19
Functional Precision Medicine in Oncology
1:10
The first mRNA cancer vaccine with pembrolizumab minimizes recurrence rate in melanoma tells Jeffrey Weber clinical investigator
1:18
Elevated Lipoprotein(a) as a Risk Enhancing Factor for Atherosclerotic Cardiovascular Disease

Spotify episodes

Apple podcasts

Google podcasts

Partner

Search by Scientific Content
Search by Congress
Search:
Date
Filters:
Lung Cance
13:28
Title Description

Lung Cancer highlights of ESMO 2023 Congress

Presenter: Luis Paz-Ares
Oncology
ESMO 2023
The import
14:17
Title Description

The importance of intensive lipid lowering in CV risk reduction: the role of early combination treatment

Presenter: Alberto Zambon
Cardiology
ESC 2023
State of a
10:39
Title Description

State of art lipid-lowering treatment in 2023

Presenter: Stephen J. Nicholls
Cardiology
ESC 2023
Lung cance
10:26
Title Description

Lung cancer highlights of the ESMO 2023 Congress

Presenter: Benjamin Besse
Oncology
ESMO 2023
Genitourin
11:41
Title Description

Genitourinary cancer highlights of ESMO 2023 Congress

Presenter: Silke Gillessen
Oncology
ESMO 2023
RCC highli
6:30
Title Description

RCC highlights of ESMO 2023 Congress

Presenter: Camillo Porta
Oncology
ESMO 2023
Melanoma h
8:15
Title Description

Melanoma highlights of ESMO 2023 Congress

Presenter: Karijn Suijkerbuijk
Oncology
ESMO 2023
Breast Can
12:18
Title Description

Breast Cancer highlights of the ESMO 2023 Congress

Presenter: Hope Rugo
Oncology
ESMO 2023
Antibody-D
3:04
Title Description

Antibody-Drug Conjugate Boosts Survival in Recurrent/Metastatic Cervical Cancer

Presenter: Krishnansu Sujata Tewari
Oncology
ESMO 2023
Treatment
7:53
Title Description

Treatment of mRCC in real world settings

Presenter: Daniel Heng
Oncology
ESMO 2023
KEYNOTE-94
7:47
Title Description

KEYNOTE-942 mRNA-Based vaccine and novel techniques in the field of melanoma

Presenter: Jeffrey Weber
Oncology
ESMO 2023
Late-break
4:43
Title Description

Late-breaking studies from ESMO 2023

Presenter: Pawel Sobczuk
Oncology
ESMO 2023
Data Shows
5:14
Title Description

Data Shows Survival Benefits with Tisotumab Vedotin in Cervical Cancer

Presenter: Ignace B. Vergote
Oncology
ESMO 2023
Induction
3:22
Title Description

Induction chemotherapy added to chemoradiation improves PFS and OS in advanced cervical cancer

Presenter: Mary McCormack
Oncology
ESMO 2023
Better use
2:47
Title Description

Better use of existing drugs increases cervical cancer survival and reduces recurrence

Presenter: Krishnansu Sujata Tewari
Oncology
ESMO 2023
Targeted C
5:56
Title Description

Targeted Combination Wins in KRAS-Positive Metastatic Colorectal Cancer

Presenter: Filippo Pietrantonio
Oncology
ESMO 2023

Lectures

Carfilzomi
6:49

Carfilzomib, Dexamethasone, and Daratumumab Versus Carfilzomib and Dexamethasone for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma (RRMM): Primary Analysis Results from the Randomized, Open-Label, Phase 3 Study Candor

Presenter: Saad Z. Usmani
Hematology
Inhibition
6:22

Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease: Results from the Phase 3 Cardinal Study

Presenter: Alexander Röth
Hematology
The QUAZAR
8:20

The QUAZAR AML-001 Maintenance Trial: Results of a Phase III International, Randomized, Double-Blind, Placebo-Controlled Study of CC-486 (Oral Formulation of Azacitidine) in Patients with Acute Myeloid Leukemia in First Remission

Presenter: Andrew H. Wei
Hematology
Validation
7:11

Validation of BCL11A As Therapeutic Target in Sickle Cell Disease: Results from the Adult Cohort of a Pilot/Feasibility Gene Therapy Trial Inducing Sustained Expression of Fetal Hemoglobin Using Post-Transcriptional Gene Silencing

Presenter: David A. Williams
Hematology
A Randomiz
4:40

A Randomized Phase 3 Trial of Blinatumomab Vs. Chemotherapy As Post-Reinduction Therapy in High and Intermediate Risk First Relapse of B-ALL in Children and Adolescents/Young Adults Demonstrates Superior Efficacy and Tolerability of Blinatumomab

Presenter: Patrick A. Brown
Hematology
CLARIFY -
7:07

CLARIFY - In stable coronary disease, patients with angina and prior myocardial infarction have a poor prognosis despite adherence to guideline recommanded therapies. Final 5-year results from the CLARIFY study

Presenter: Emmanuel Sorbets
Cardiology
SWEDEHEART
5:26

SWEDEHEART: Secondary prevention medication after coronary artery bypass surgery and long-term mortality: A longitudinal population-based study from the SWEDEHEART registry

Presenter: Erik Bjoerklund
Cardiology
ICD use in
4:31

ICD use in HF - Association between implantable cardioverter-defibrillator use for primary prevention and mortality: a prospective propensity-score matched study

Presenter: Benedikt Schrange
Cardiology
PURE: Impa
10:51

PURE: Impact of modifiable risk factors on cardiovascular disease and mortality

Presenter: Salim Yusuf
Cardiology
RAPIDTnT:
5:37

RAPIDTnT: A randomised trial of a 1-hour troponin T protocol in suspected acute coronary syndromes: the Rapid Assessment of Possible ACS In the emergency Department with high sensitivity Troponin T

Presenter: Derek Chew
Cardiology
ENTRUST-AF
7:45

ENTRUST-AF PCI - Edoxaban-based versus vitamin-K-antagonist-based anti-thrombotic regimen following successful coronary stenting in atrial fibrillation patients

Presenter: Andreas Goette
Cardiology
POPular Ge
6:51

POPular Genetics - Genotype-guided oral P2Y12-inhibition in patients with St-segment elevation myocardial infarction undergoing primary PCI : a randomized, open-label, multicenter trial

Presenter: Jurrien M. Ten Berg
Cardiology
Combined e
5:03

Combined effect of lower LDL-C and lower SBP on the lifetime risk od cardiovascular disease

Presenter: Brian A. Ference
Cardiology
AFIRE - Ri
4:47

AFIRE - Rivaroxaban monotherapy versus dual therapy in patients with atrial fibrillation and stable coronary artery disease

Presenter: Satoshi Yasuda
Cardiology
GALACTIC -
7:23

GALACTIC - Goal-directed AfterLoad Reduction in Acute Congestive Cardiac Decompensation: a randomized controlled trial

Presenter: Christian Eugen Mueller
Cardiology
Salt subst
5:16

Salt substitution and community-wide reduction in blood pressure and hypertension incidence

Presenter: J. Jaime Miranda
Cardiology
How to man
1:00
Title Description

How to manage isolated systolic hypertension in the young?

Presenter: Paolo Palatini
Cardiology
Blood pres
1:34
Title Description

Blood pressure monitoring in general and what we can do to encourage people.

Presenter: Neil Poulter
Cardiology
How to man
1:08
Title Description

How to manage masked and masked uncontrolled hypertension?

Presenter: Paolo Palatini
Cardiology
ESMO 2023
1:13
Title Description

ESMO 2023 Scientific Chair's welcome and invitation to next year's ESMO Congress

Presenter: Silke Gillessen
Oncology
Once-weekl
1:17
Title Description

Once-weekly semaglutide in people with HFpEF and obesity

Presenter: Mikhail Kosiborod
Cardiology
Should ABP
1:31
Title Description

Should ABPM parameters have a role in clinical practice?

Presenter: Paolo Palatini
Cardiology
On the mos
1:09
Title Description

On the most important key points on the diagnosis of Hypertension in the new ESH2023 guidelines

Presenter: Bryan Williams
Cardiology
2023 ESC G
1:13
Title Description

2023 ESC Guidelines for the Management of Endocarditis

Presenter: Michael A. Borger
Cardiology
How to mea
1:37
Title Description

How to measure blood pressure in the very obese patients?

Presenter: Paolo Palatini
Cardiology
The keypoi
1:14
Title Description

The keypoints of 2023 ESC Guidelines for the Management of Cardiomyopathies

Presenter: Juan Pablo Kaski
Cardiology
How to bes
1:20
Title Description

How to best perform office blood pressure management?

Presenter: Paolo Palatini
Cardiology
Key points
1:09
Title Description

Key points from the newly updated ESC Heart Failure guidelines

Presenter: Marco Metra
Cardiology
Do overwei
0:54
Title Description

Do overweight and obesity confer an additional risk of CAD in patients with FH?

Presenter: Amany Elshorbagy
Cardiology
Interrupti
1:17
Title Description

Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer

Presenter: Matteo Lambertini
Oncology
The Omega-
1:17
Title Description

The Omega-3 Mystery: New Evidence Supports the Therapeutic Value of EPA

Presenter: Eliot A. Brinton
Cardiology
The issue
1:15
Title Description

The issue of adjuvant vs neoadjuvant treatment

Presenter: Paolo A. Ascierto
Oncology